Each of these hallmarks can be dissected in the synchronous MycERTAM;Bcl-xL reversibly switchable model of Myc-induced beta cell tumor progression [28], a capability that has enabled us to assess the contribution made by CTS L at different stages of Myc-driven tumorigenesis. Here, MYC is linked to pancreatic insulin-producing neuroendocrine tumor.